BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 20172840)

  • 21. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei.
    Van Rensburg SJ; Cook-Mozaffari P; Van Schalkwyk DJ; Van der Watt JJ; Vincent TJ; Purchase IF
    Br J Cancer; 1985 May; 51(5):713-26. PubMed ID: 2986667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of Liver Cancer in Africa: Current and Future Trends.
    Okeke E; Davwar PM; Roberts L; Sartorius K; Spearman W; Malu A; Duguru M
    Semin Liver Dis; 2020 May; 40(2):111-123. PubMed ID: 31726474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV and hepatocellular and esophageal carcinomas related to consumption of mycotoxin-prone foods in sub-Saharan Africa.
    Williams JH; Grubb JA; Davis JW; Wang JS; Jolly PE; Ankrah NA; Ellis WO; Afriyie-Gyawu E; Johnson NM; Robinson AG; Phillips TD
    Am J Clin Nutr; 2010 Jul; 92(1):154-60. PubMed ID: 20484447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards global control of liver cancer?
    Stuver SO
    Semin Cancer Biol; 1998 Aug; 8(4):299-306. PubMed ID: 9870036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between hepatitis B virus infection and exposure to aflatoxins in the development of hepatocellular carcinoma: a molecular epidemiological approach.
    Sylla A; Diallo MS; Castegnaro J; Wild CP
    Mutat Res; 1999 Jul; 428(1-2):187-96. PubMed ID: 10517992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergism between hepatitis B virus and aflatoxin in hepatocellular carcinoma.
    Ayoola EA
    IARC Sci Publ; 1984; (63):167-79. PubMed ID: 6100268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory considerations of aflatoxin contamination of food in Mexico.
    Guzmán-de-Peña D; Peña-Cabriales JJ
    Rev Latinoam Microbiol; 2005; 47(3-4):160-4. PubMed ID: 17061539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention.
    Wild CP; Montesano R
    Cancer Lett; 2009 Dec; 286(1):22-8. PubMed ID: 19345001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changing epidemiology of hepatocellular carcinoma in Asia.
    Goh GB; Chang PE; Tan CK
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):919-28. PubMed ID: 26651253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aflatoxin and liver cancer.
    Jackson PE; Groopman JD
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Dec; 13(4):545-55. PubMed ID: 10654919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, India.
    Anitha S; Raghunadharao D; Waliyar F; Sudini H; Parveen M; Rao R; Kumar PL
    Mutat Res Genet Toxicol Environ Mutagen; 2014 May; 766():23-8. PubMed ID: 24657665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiological and etiological variations in hepatocellular carcinoma.
    Sagnelli E; Macera M; Russo A; Coppola N; Sagnelli C
    Infection; 2020 Feb; 48(1):7-17. PubMed ID: 31347138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aflatoxins and fumonisins in corn from the high-incidence area for human hepatocellular carcinoma in Guangxi, China.
    Li FQ; Yoshizawa T; Kawamura O; Luo XY; Li YW
    J Agric Food Chem; 2001 Aug; 49(8):4122-6. PubMed ID: 11513719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma.
    Zhang W; He H; Zang M; Wu Q; Zhao H; Lu LL; Ma P; Zheng H; Wang N; Zhang Y; He S; Chen X; Wu Z; Wang X; Cai J; Liu Z; Sun Z; Zeng YX; Qu C; Jiao Y
    Gastroenterology; 2017 Jul; 153(1):249-262.e2. PubMed ID: 28363643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aflatoxin and PAH exposure biomarkers in a U.S. population with a high incidence of hepatocellular carcinoma.
    Johnson NM; Qian G; Xu L; Tietze D; Marroquin-Cardona A; Robinson A; Rodriguez M; Kaufman L; Cunningham K; Wittmer J; Guerra F; Donnelly KC; Williams JH; Wang JS; Phillips TD
    Sci Total Environ; 2010 Nov; 408(23):6027-31. PubMed ID: 20870273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and natural history of hepatocellular carcinoma.
    McGlynn KA; London WT
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):3-23. PubMed ID: 15757802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiological characteristics and risk factors of hepatocellular carcinoma.
    Chen CJ; Yu MW; Liaw YF
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S294-308. PubMed ID: 9407350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epidemiology and prevention of hepatocellular carcinoma.
    Monto A; Wright TL
    Semin Oncol; 2001 Oct; 28(5):441-9. PubMed ID: 11685737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.